Advanced therapies are evolving rapidly, and with that evolution comes a critical challenge: ensuring safe, scalable and compliant manufacturing. On Wednesday March 11, 2026, the fifth edition of the Dutch ATMP Summit brings together leading experts from across the field to address exactly that.
Hosted in Leiden, the summit offers a focused program featuring specialists from organizations including LUMC, NTrans Technologies, Fuse Vectors, Zelluna, Solvias and Progress – Experts in Life Sciences. The sessions dive into core topics such as gene editing innovation, synthetic AAV manufacturing, advanced analytics, CQA monitoring and new validation strategies driven by AI and automation.
With highly rated previous editions and a growing community of ATMP professionals, the summit is known for its strong content, practical insights and valuable networking. New this year is a dedicated Poster Session, offering attendees the opportunity to share work that is shaping the next generation of advanced therapies.
If you work in ATMP development, manufacturing, quality or regulatory affairs, this event delivers concentrated expertise and actionable insights to prepare your organization for the decade ahead.
Secure your ticket through the event website and join us on March 11, 2026, at Corpus Leiden on https://www.dutchatmpsummit.com/